معرفی
Nabeel Nabulsi is a Senior Research Scientist in the Department of Radiology & Biomedical Imaging at Yale School of Medicine. He serves as Associate Director of the Yale PET Center, Deputy Director of the PET Center Chemistry Section, and Director of Regulatory Affairs and Quality Control at the Yale PET Center. His research focuses on developing radiopharmaceuticals for PET imaging in CNS disorders and oncology, particularly targeting Alzheimer's disease, pancreatic cancer, and FAAH inhibition.
- BA in Chemistry (pre-Medicine), University of Texas at Arlington (1980)
- MS in Organic Chemistry, Texas Tech University (1984)
- PhD in Organic/Bioorganic Chemistry, Louisiana State University (1991)
Dr. Nabulsi specializes in synthetic methodologies for radiopharmaceuticals with short half-life radionuclides (C-11, F-18). His work explores:
- Synaptic density imaging via SV2A radioligands in Alzheimer's and schizophrenia
- Neuroimmune mechanisms in PTSD and alcohol use disorder
- Pancreatic cancer detection through PepT1 transporter-targeted radiotracers
- Endocannabinoid system analysis in psychiatric disorders
- HDAC6 imaging for neurodegenerative research
Key collaborations include Richard Carson, Jean-Dominique Gallezot, and Yiyun Huang. He contributes to clinical trials on synaptic density in Alzheimer's disease and cortisol metabolism imaging.